{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:03:54Z","timestamp":1793865834570,"version":"4.6.1"},"reference-count":44,"publisher":"The Journal of Rheumatology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective.<\/jats:title>\n                    <jats:p>To analyze clinical characteristics, survival, causes of death, and risk factors associated with mortality in patients with adult-onset idiopathic inflammatory myopathies (IIM) in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We retrospectively investigated 197 patients diagnosed with adult-onset IIM at our hospital from 1984 to 2009 according to Bohan and Peter criteria for polymyositis (PM)\/dermatomyositis (DM) and modified Sontheimer\u2019s criteria for clinically amyopathic DM (ADM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Survival in the whole group at 1, 5, and 10 years was 85%, 75%, and 67%, respectively. Mortality in cancer-associated myositis was the worst (25% at 5 yrs), followed by clinically ADM (61% at 5 yrs) and primary DM (77% at 5 yrs). Primary DM had significantly low survival compared to primary PM (91% at 5 yrs; p = 0.0427). Among the 53 patients who died were 6 patients with ADM (11%) and 20 patients with primary DM (38%). Interstitial lung disease (ILD) was the main cause of death in clinically ADM (71%) and primary DM (60%), most of which occurred within the first few months. Fewer patients died in primary PM (9%) and overlap myositis (13%). Independent risk factors for death were older age (HR 1.031; 95% CI 1.009\u20131.053) and skin ulcers (HR 3.018; 95% CI 1.340\u20136.796) in the whole group and ILD with mild serum creatine kinase levels (&lt; 500 IU\/l; HR 3.537; 95% CI 1.260\u20139.928) in primary DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion.<\/jats:title>\n                    <jats:p>Survival of clinically ADM and primary DM was low, mainly due to fatal ILD, compared to primary PM. Establishing therapeutic strategy for ILD may improve the survival in our patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.101002","type":"journal-article","created":{"date-parts":[[2011,5,15]],"date-time":"2011-05-15T20:13:25Z","timestamp":1305490405000},"page":"1636-1643","source":"Crossref","is-referenced-by-count":120,"title":["Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan"],"prefix":"10.3899","volume":"38","author":[{"given":"YOSHIOKI","family":"YAMASAKI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEHIRO","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHIKO","family":"OHKUBO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAOMI","family":"YAMASAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOHEI","family":"AZUMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HITOSHI","family":"OGAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MACHIKO","family":"MIZUSHIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHOICHI","family":"OZAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2011,5,15]]},"reference":[{"key":"2018112909264437000_38.8.1636.1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199811000-00008"},{"key":"2018112909264437000_38.8.1636.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780140210"},{"key":"2018112909264437000_38.8.1636.3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780280303","article-title":"Prognostic factors in polymyositis\/dermatomyositis. A computer-assisted analysis of ninety-two cases","volume":"28","author":"Benbassat","year":"1985","journal-title":"Arthritis Rheum"},{"key":"2018112909264437000_38.8.1636.4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0889-857X(21)00378-1","article-title":"The treatment of myositis. How to approach resistant disease","volume":"21","author":"Adams","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"key":"2018112909264437000_38.8.1636.5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine"},{"key":"2018112909264437000_38.8.1636.6","first-page":"263","article-title":"Long-term prognosis of 69 patients with dermatomyositis or polymyositis","volume":"14","author":"Maugars","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909264437000_38.8.1636.7","first-page":"2230","article-title":"Polymyositis and dermatomyositis: Short term and longterm outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"2018112909264437000_38.8.1636.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.22"},{"key":"2018112909264437000_38.8.1636.9","doi-asserted-by":"publisher","DOI":"10.1383\/medc.32.3.35.28615"},{"key":"2018112909264437000_38.8.1636.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-1164-z"},{"key":"2018112909264437000_38.8.1636.11","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600622603"},{"key":"2018112909264437000_38.8.1636.12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/187153006779025775","article-title":"Recent advances in the treatment of interstitial lung disease in patients with polymyositis\/dermatomyositis","volume":"6","author":"Kameda","year":"2006","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2018112909264437000_38.8.1636.13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3760\/cma.j.issn.0366-6999.2010.05.002","article-title":"Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: A retrospective study","volume":"123","author":"Ji","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"2018112909264437000_38.8.1636.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"2018112909264437000_38.8.1636.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502202920807"},{"key":"2018112909264437000_38.8.1636.16","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199911000-00006"},{"key":"2018112909264437000_38.8.1636.17","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120621"},{"key":"2018112909264437000_38.8.1636.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.10.041"},{"key":"2018112909264437000_38.8.1636.19","first-page":"438","article-title":"Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study","volume":"35","author":"Andras","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909264437000_38.8.1636.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"2018112909264437000_38.8.1636.21","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230510"},{"key":"2018112909264437000_38.8.1636.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"2018112909264437000_38.8.1636.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360309"},{"key":"2018112909264437000_38.8.1636.24","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0562-9"},{"key":"2018112909264437000_38.8.1636.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704"},{"key":"2018112909264437000_38.8.1636.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.21883"},{"key":"2018112909264437000_38.8.1636.27","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Statist"},{"key":"2018112909264437000_38.8.1636.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-010-0362-y"},{"key":"2018112909264437000_38.8.1636.29","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.328"},{"key":"2018112909264437000_38.8.1636.30","first-page":"S109","article-title":"Mortality in idiopathic inflammatory myopathies","volume":"26","author":"Lundberg","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909264437000_38.8.1636.31","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(86)90014-4"},{"key":"2018112909264437000_38.8.1636.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14368-1"},{"key":"2018112909264437000_38.8.1636.33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh723"},{"key":"2018112909264437000_38.8.1636.34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1067\/mjd.2003.199","article-title":"Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis","volume":"48","author":"Sontheimer","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"2018112909264437000_38.8.1636.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2740"},{"key":"2018112909264437000_38.8.1636.36","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00026703"},{"key":"2018112909264437000_38.8.1636.37","first-page":"58","article-title":"Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis","volume":"32","author":"Fujisawa","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909264437000_38.8.1636.38","first-page":"260","article-title":"High-resolution computed tomography characterization of interstitial lung diseases in polymyositis\/dermatomyositis","volume":"35","author":"Hayashi","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909264437000_38.8.1636.39","first-page":"1527","article-title":"Corticosteroid resistant interstitial pneumonitis in dermatomyositis\/polymyositis: Prediction and treatment with cyclosporine","volume":"26","author":"Nawata","year":"1999","journal-title":"J Rheumatol"},{"key":"2018112909264437000_38.8.1636.40","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.5.372"},{"key":"2018112909264437000_38.8.1636.41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1346-8138.1994.tb01818.x","article-title":"Dermatomyositis with multiple skin ulcers showing vasculitis and membrano-cystic lesion","volume":"21","author":"Yamamoto","year":"1994","journal-title":"J Dermatol"},{"key":"2018112909264437000_38.8.1636.42","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2002.50012"},{"key":"2018112909264437000_38.8.1636.43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel112"},{"key":"2018112909264437000_38.8.1636.44","doi-asserted-by":"publisher","DOI":"10.1002\/art.21240"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.101002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T14:46:59Z","timestamp":1712414819000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.101002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,15]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,1]]},"published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.3899\/jrheum.101002"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.101002","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,15]]}}}